Structural Cardiology Follow-up and TEE for Atrial Flutter
For a patient with new atrial flutter, a structural cardiology follow-up with transthoracic echocardiography (TTE) is indicated, but a TEE is only necessary if cardioversion is planned within 48 hours without adequate anticoagulation or if TTE is non-diagnostic and clinical suspicion for structural disease or thrombus remains high. 1, 2
Initial Imaging Approach
Start with transthoracic echocardiography (TTE), not TEE. The American Heart Association recommends TTE as the initial imaging test for newly diagnosed atrial flutter, providing essential assessment of cardiac structure and function that guides management decisions 1. This evaluation should include:
- Left atrial and right atrial size assessment, which predict arrhythmia recurrence 1
- Left ventricular size, wall thickness, and systolic function 1
- Right ventricular size and function 1
- Valvular structure and function (stenosis or regurgitation) 1
- Assessment for structural heart disease that may contribute to atrial flutter 1
When TEE Becomes Necessary
TEE is indicated in specific clinical scenarios, not routinely for all atrial flutter patients. The following situations warrant TEE:
Pre-Cardioversion Assessment
- TEE is required before cardioversion in patients with atrial flutter lasting >48 hours who have not been adequately anticoagulated 1, 2
- TEE excludes left atrial thrombus, particularly in the left atrial appendage, which is a clear contraindication to cardioversion 3
- TEE has 51% sensitivity for detecting shunts compared to 32% for TTE, making it superior for excluding cardiac sources of emboli 4
When TTE is Non-Diagnostic
- If TTE provides poor image quality or inconclusive findings, TEE can be useful for clinical decision-making 2
- TEE is particularly valuable for assessing the atrial septum, systemic and pulmonary venous connections, and can provide new diagnostic information in 56% of cases where TTE is inadequate 4
Suspected Complications or Device Infections
- All adults suspected of having cardiac implantable electronic device (CIED)-related endocarditis should undergo TEE to evaluate the left-sided heart valves, even if transthoracic views have demonstrated lead-adherent masses 2
- TEE has approximately 90% sensitivity for detecting prosthetic valve vegetations and lead infections, compared to only 25-40% for TTE 2, 5
- Patients with suspected CIED infection who have positive blood cultures or recent antimicrobial therapy should undergo TEE 2
Structural Cardiology Consultation Indications
A structural cardiology follow-up is appropriate if any of the following are identified on TTE:
- Significant valvular heart disease requiring intervention planning 1
- Structural heart disease contributing to arrhythmia (e.g., atrial septal defect, patent foramen ovale) 1, 4
- Left ventricular dysfunction or cardiomyopathy requiring specialized management 1
- Congenital heart disease in adults requiring expert evaluation 2
Important Caveats
Do not order TEE reflexively without first obtaining TTE. TTE has 90% specificity for most cardiac pathology and should guide the decision for further imaging 5. TEE is semi-invasive with potential complications including oropharyngeal, esophageal, or gastric trauma, and examination may be unsuccessful in 3-5% of patients 6, 4.
TEE has specific blind spots: It provides limited visualization of the right ventricular outflow tract, pulmonary valve, distal right pulmonary artery, proximal left pulmonary artery, and apical-anterior septum 4. These areas may require complementary TTE views 2.
If cardioversion is planned >48 hours out with adequate anticoagulation (therapeutic for 3 weeks), TEE may not be necessary 7, 3. The conventional anticoagulation strategy (3 weeks before, 4 weeks after cardioversion) is equally safe as TEE-guided early cardioversion when guidelines are properly followed 7.